Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study - Concepedia

Concepedia

Publication | Closed Access

Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study

103

Citations

19

References

2003

Year

B. Guess, Mark C. Scholz, Stephen B. Strum, Richard Y. Lam, Henry J. Johnson, Robert I. Jennrich

Prostate Cancer and Prostatic Diseases

UrologyGenitourinary CancerMedicinePathologyModified Citrus PectinProstatic DiseaseOncologyProstate-specific Antigen

References

	Year	Citations

Page 1